Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:MSEX
NasdaqGS:MSEXWater Utilities

Is Middlesex Water (MSEX) Fairly Priced After Recent Share Price Rebound?

If you are wondering whether Middlesex Water at around US$54.55 is a bargain or just fairly priced, you are not alone, many investors are asking the same question. The stock has been fairly quiet over the last week with a 0.5% decline, but the 4.1% move over 30 days and 8.5% return year to date contrast with a 3.5% decline over 1 year and deeper 21.8% and 16.4% declines over 3 and 5 years. Recent attention on regulated utilities and their capital needs has kept investor focus on balance...
OB:HAFNI
OB:HAFNIOil and Gas

Hafnia (OB:HAFNI) Is Up 7.1% After Strong Q4 Profit And 16th Straight Dividend Hike

Hafnia Limited recently reported fourth-quarter 2025 sales of US$368.4 million and net income of US$109.7 million, alongside a full-year 2025 net income of US$339.68 million on sales of US$2.28 billion. Despite full-year earnings easing from the prior year, Hafnia declared a fourth-quarter cash dividend of US$0.1762 per share with an 80% payout ratio, marking its 16th consecutive quarter of consistent dividends and highlighting management’s emphasis on returning cash to shareholders. We will...
SWX:ZURN
SWX:ZURNInsurance

Zurich Beazley Deal Tests Equity Dilution Against Promised Synergies

Zurich Insurance Group has confirmed the acquisition of UK based insurer Beazley, following completion of an accelerated equity offering to fund the deal. The transaction expands Zurich's presence in international insurance markets and follows investor backing via fresh equity capital. The company, trading as SWX:ZURN, remains in focus as integration plans and capital impacts come into view for shareholders. Zurich Insurance Group, ticker SWX:ZURN, is approaching this deal with a current...
TSX:TLO
TSX:TLOMetals and Mining

Is Talon Metals’ (TSX:TLO) Exploration-Only Focus Reframing Its Long-Term Nickel and Copper Narrative?

In recent days, Talon Metals reported higher trading activity following updated corporate disclosures that emphasized its focus on nickel and copper at the Tamarack project and iron at the Trairão project, all within its exploration and development portfolio. An important nuance is that Talon Metals still has no active commercial production, so market attention centers on exploration progress and project potential rather than operating results. With this context, we’ll examine how Talon...
NYSE:PLOW
NYSE:PLOWMachinery

A Look At Douglas Dynamics (PLOW) Valuation After Earnings Beat Guidance And Dividend Confirmation

Why Douglas Dynamics (PLOW) is back on investors' radar Douglas Dynamics (PLOW) has drawn fresh attention after reporting fourth quarter 2025 earnings, issuing net sales guidance for 2026 between US$710 million and US$760 million, and affirming its quarterly dividend. See our latest analysis for Douglas Dynamics. The latest earnings release, 2026 net sales guidance and dividend affirmation come after a strong run in the shares, with a 30 day share price return of 24.44% and a 1 year total...
NYSE:EPR
NYSE:EPRSpecialized REITs

EPR Properties Leadership Shift Tests Experiential Growth And Richer Dividend

EPR Properties (NYSE:EPR) announced the retirement of Chief Investment Officer Gregory Zimmerman. Benjamin Fox has been appointed as the new CIO as part of the leadership transition. The company recently completed acquisitions in experiential real estate assets. EPR also approved a 5.1% dividend increase. EPR Properties, trading at $59.94, operates in the experiential net lease space. Its recent moves come after multi year share returns of 82.4% over 3 years and 73.6% over 5 years. In the...
NasdaqGS:UPWK
NasdaqGS:UPWKProfessional Services

Will Upwork's (UPWK) New US$300 Million Buyback Shift Its Capital Allocation Narrative?

In February 2026, Upwork Inc. announced that its Board of Directors had authorized an open-ended share repurchase program of up to US$300,000,000 of its common stock. This sizable buyback authorization highlights management’s current priorities for capital allocation, including potential effects on share count, cash deployment, and balance sheet flexibility. We’ll now examine how this new US$300,000,000 buyback program could influence Upwork’s existing investment narrative and longer-term...
SEHK:2689
SEHK:2689Forestry

Assessing Nine Dragons Paper (SEHK:2689) Valuation After Half‑Year Earnings And Profitability Jump

Earnings jump puts Nine Dragons Paper in focus Nine Dragons Paper (Holdings) (SEHK:2689) is on investors' radar after reporting half year sales of CN¥37,220.77 million and net income of CN¥2,167.76 million, both higher than the prior year period. Basic and diluted earnings per share from continuing operations came in at CN¥0.42, compared with CN¥0.10 a year earlier. This gives shareholders fresh numbers to assess the paper maker's current profitability. See our latest analysis for Nine...
NYSE:DXC
NYSE:DXCIT

Is DXC Technology (DXC) Now A Potential Opportunity After Prolonged Share Price Weakness

Wondering whether DXC Technology at around US$12.19 is starting to look like a bargain or a value trap? This article walks through what the numbers actually say about the stock. The share price has had a mixed run, with a 2.9% return over the last 7 days, a 15.5% decline over 30 days, a 13.4% decline year to date, and a 32.7% decline over the past year. Over longer periods, the 3 year and 5 year returns sit at declines of 57.2% and 56.5% respectively. These moves have kept DXC Technology on...
NasdaqGS:AVT
NasdaqGS:AVTElectronic

Is It Too Late To Consider Avnet (AVT) After Its Strong Multi Year Share Price Run?

If you are wondering whether Avnet at around US$64.98 is still offering value or starting to look fully priced, you are asking the right question for a stock that gets a lot of attention from value focused investors. The share price has been active recently, with a 3.4% decline over the last 7 days, a 4.2% return over 30 days, and longer term returns of 31.7% year to date, 35.8% over 1 year, 55.2% over 3 years, and 87.7% over 5 years. Recent coverage of Avnet has centered on its role as a...
TSX:VNP
TSX:VNPChemicals

Why 5N Plus (TSX:VNP) Is Up 9.0% After Record 2025 Earnings And US$18.1 Million Grant

5N Plus Inc. has reported its full-year 2025 results, with sales rising to US$391.06 million and net income reaching US$50.57 million, alongside sharply higher earnings per share from continuing operations versus the prior year. Management also outlined a positive 2026 outlook and highlighted an US$18.1 million U.S. government grant to expand germanium recycling and refining capacity, reinforcing the company’s position in specialty semiconductors and advanced materials. With record 2025...
TSX:EMP.A
TSX:EMP.AConsumer Retailing

A Look At Empire (TSX:EMP.A) Valuation After Leadership Team Overhaul And Pharmacy Growth Push

Empire (TSX:EMP.A) has reshaped its senior team following Pierre St-Laurent’s recent move to chief executive, appointing new leaders for customer, retail operations, and pharmacy oversight. See our latest analysis for Empire. At a share price of CA$49.21, Empire has seen a 10.63% 1 month share price return and a 10.54% 1 year total shareholder return. This suggests momentum has picked up recently while longer term holders have also seen gains. If this executive reshuffle has you thinking more...
NYSE:DRD
NYSE:DRDMetals and Mining

DRDGOLD’s Vision 2028 Work And What It May Mean For Valuation

DRDGOLD is progressing its Vision 2028 initiative, focused on infrastructure upgrades and operational improvements across its tailings operations. The company is moving ahead with plans to link processing plants and restart deposition at key tailings storage facilities. These developments are intended to support longer term operating plans and more efficient use of existing assets. For investors watching NYSE:DRD, the Vision 2028 work sits against a share price of $38.32 and multi year...
NasdaqCM:RR
NasdaqCM:RRMachinery

Richtech Robotics Lawsuits Put Microsoft Ties And Investor Trust In Focus

Multiple law firms have filed class action lawsuits against Richtech Robotics (NasdaqCM:RR) alleging the company misled investors about its relationship with Microsoft. The suits claim Richtech described a collaborative and commercial partnership with Microsoft, while Microsoft has reportedly denied having a commercial relationship. Investors are focusing on potential disclosure issues, legal exposure, and the impact of these claims on Richtech's credibility and future capital...
NYSE:CRI
NYSE:CRILuxury

Carter's Revenue Turnaround Meets Store Closures And Product Shift Plan

Carter's (NYSE:CRI) has reported its first year over year revenue growth since 2021, supported by stronger retail sales and demand creation efforts. The company plans to close about 150 lower margin stores by 2028 while expanding higher priced product assortments for Gen Z and Millennial families. Carter's is also putting more emphasis on direct to consumer channels as it adjusts to changing shopping habits and cost pressures. Carter's shares recently closed at $34.95, with the stock down...
NasdaqGS:ITRI
NasdaqGS:ITRIElectronic

Itron Raises US$700m In Convertible Notes To Support Grid Modernisation

Itron (NasdaqGS:ITRI) has completed a $700 million offering of convertible senior notes. The offering follows the company’s fourth quarter results, which were described as robust and above expectations. The transaction adds a sizable pool of capital that can influence Itron’s balance sheet and future investment decisions. Itron focuses on technology and services that help utilities and cities manage energy, water, and smart infrastructure. For investors watching the broader push toward grid...
SWX:SDZ
SWX:SDZPharmaceuticals

EU Ranluspec Approval Adds New Dimension To Sandoz Ophthalmology Growth Story

Sandoz Group (SWX:SDZ) has received EU marketing authorization for Ranluspec. The approval expands the company’s biosimilars portfolio into the ophthalmology segment. The decision supports an expected product launch later in 2026 across European markets. For you as an investor, this represents a business development in a high-value area of medicine. Sandoz focuses on biosimilars and generics, and Ranluspec adds another product aimed at chronic eye conditions where long-term treatment is...
TSX:GOOS
TSX:GOOSLuxury

Is It Time To Reassess Canada Goose Holdings (TSX:GOOS) After Its Mixed Share Price Performance?

If you are wondering whether Canada Goose Holdings is attractively priced or still carrying premium expectations, this article walks through the numbers in a clear, practical way. The share price closed at C$16.38 most recently, with a 15.8% gain over the last year but declines of 1.6% over 7 days, 0.8% over 30 days, and 11.8% year to date. This can signal shifting views on both growth potential and risk. That mix of returns sits against a longer three year return of 37.3% and a five year...
TSX:NEO
TSX:NEOChemicals

Is Neo Performance Materials (TSX:NEO) Getting Ahead Of Itself After A 275% One-Year Surge?

If you are wondering whether Neo Performance Materials at around $27.61 offers real value or is running ahead of itself, you are not alone. The stock has moved sharply, with returns of 19.5% over 7 days, 44.1% over 30 days, 63.5% year to date, 274.6% over 1 year, 209.1% over 3 years and 83.8% over 5 years. Recent news coverage around Neo Performance Materials has focused on the company as part of the broader rare earth and advanced materials space. This area often attracts attention when...
CPSE:CARL B
CPSE:CARL BBeverage

Carlsberg India IPO Talks Put Spotlight On Growth And Shareholder Value

Carlsberg has confirmed it is considering an IPO of its India business. The company publicly acknowledged ongoing speculation around the India listing plans. The potential IPO would give investors a direct way to gain exposure to Carlsberg’s India operations. For investors watching CPSE:CARL B, the confirmation around a possible India IPO comes at a time when the shares trade at DKK969.2. The stock is up 13.6% over the past 30 days and 17.4% year to date, with a 12.3% return over 5 years...
NYSE:SJM
NYSE:SJMFood

The Bull Case For J. M. Smucker (SJM) Could Change Following Mixed Q3 Results And Governance Shift

The J. M. Smucker Company recently reported fiscal 2026 third-quarter results showing higher net sales of US$2,339.4 million but a larger net loss of US$724.2 million, alongside slightly narrowed full-year net sales guidance of 3.5% to 4.0% growth and projected diluted EPS in the range of US$1.89 to US$1.39 loss. At the same time, Smucker moved to strengthen its governance and product portfolio by adding two financially experienced independent directors following engagement with Elliott...
NYSE:MSCI
NYSE:MSCICapital Markets

Is It Time To Reassess MSCI (MSCI) After Recent Valuation Rethink For Index Providers

If you are wondering whether MSCI is fairly priced or offering an opportunity right now, it helps to step back and look closely at what the current share price really reflects. The stock last closed at US$573.88, with recent returns of 6.6% over 7 days, a 5.8% decline over 30 days, 1.5% year to date, a 1.2% decline over 1 year, 9.6% over 3 years and 50.4% over 5 years. Taken together, these figures give a mixed picture of recent momentum and risk sentiment. Recent news around MSCI has...
BME:TEF
BME:TEFTelecom

Telefónica Expands UK Fibre And Modernizes Spain Operations After Recent Losses

Telefónica, through its nexfibre joint venture, announced the acquisition of UK fibre provider Substantial Group, aiming to expand fibre infrastructure in the UK. Telefónica Spain is adopting Red Hat OpenShift to modernize and unify IT and network functions across its operations. The company, listed as BME:TEF, last closed at €3.724. For investors watching BME:TEF, these moves come as the stock trades at €3.724, with a 9.0% return over the past 30 days and a 7.0% return year to date. The...
NasdaqGM:SUPN
NasdaqGM:SUPNPharmaceuticals

Is It Too Late To Consider Supernus Pharmaceuticals (SUPN) After A 74% One-Year Surge?

If you are wondering whether Supernus Pharmaceuticals at around US$55.09 is still offering value after its recent run, you are not alone. The stock has posted returns of 8.7% over the past 7 days, 14.4% over 30 days, 11.4% year to date and 73.6% over 1 year, with longer term returns of 43.5% over 3 years and 116.0% over 5 years. These moves sit against a backdrop of continuing interest in Supernus Pharmaceuticals as a neurology focused drug maker. Investors are paying close attention to how...